Developers: | GT Medical Technologies |
Date of the premiere of the system: | December, 2020 |
Branches: | Pharmaceutics, medicine, health care |
2020: The announcement of GammaTile - the system of radiation therapy of a brain
In the middle of December, 2020 the GT Medical Technologies company released the GammaTile system which can provide local radiation therapy of sections of a brain for removal of a tumor. The purpose of release of this device - to reduce risk of a recurrence of a tumor and to increase survival of patients.
Treatment consists in implantation of the radioactive grains concluded in collagenic substrate. It is easy to place them in the place of coretraction at the end of a surgical procedure for removal of bulk of a tumor. Local action of GammaTiles helps to reduce ghost effects of radiation therapy, such as hair loss, and three-dimensional structure of Zernos allows to place them directly in the place of coretraction as much as possible to influence residual tumor cells and to save nearby healthy fabrics.
The president and the CEO of GT Medical Technologies Matthew Likens explained that one of main advantages of GammaTile Therapy is an opportunity to implant the device in the last five minutes of transaction. It saves patients from additional visits of hospital or clinic for radiation therapy, thereby reducing risks and ghost effects of repeated radiation. Collagenic GammaTile substrate is designed to protect from radiation healthy fabrics, and the radiation of grains not infinitely. Up to 90% of radiation it falls on the first 33 days after implantation. It is considered that the radiation level approaches zero in 100 days after implantation.
In general, in clinical trials the survival of patients at therapy of GammaTile grew whereas the frequency of complications remained equal or smaller, than with the existing treatment methods. Besides, the new published data assume that therapy of GammaTile can become a safe and effective method of treatment which slows down progressing at patients with the aggressive tumors of a brain known as meningioma.[1]